Ascendis Pharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ascendis Pharma Stock Summary

Ascendis Pharma competes with Apellis Pharmaceuticals, Akero Therapeutics, Blueprint Medicines, Replimune, and Nuvalent. Ascendis Pharma AS, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Ascendis Pharma is traded on NASDAQ Exchange in the United States.

Ascendis Pharma Key Financial Ratios

Ascendis Pharma Key Balance Sheet Accounts

Ascendis Pharma Key Income Statement Accounts

Ascendis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ascendis Pharma's current stock value. Our valuation model uses many indicators to compare Ascendis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ascendis Pharma competition to find correlations between indicators driving Ascendis Pharma's intrinsic value. More Info.Ascendis Pharma AS is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Ascendis Pharma's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ascendis Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Ascendis Pharma AS Systematic Risk

Today, most investors in Ascendis Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ascendis Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ascendis Pharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ascendis Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ascendis Pharma AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ascendis Pharma AS based on widely used predictive technical indicators. In general, we focus on analyzing Ascendis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ascendis Pharma's daily price indicators and compare them against related drivers.

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.